Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Esperanza Patient has no evidence of intact HIV blueprints that can produce more virus.
One new approach protects CD4 cells against HIV entry, while another snips out viral genes in infected cells.
Different mechanisms suppressed the virus in each person.
NIH-funded study finds reduced levels of HIV in bone marrow, spleen and brain after nanoparticle therapy.
Scientists are getting a better sense of the risks and benefits of treatment interruptions in cure research.
Early treatment is linked to a smaller viral reservoir, but blocking IL-10 and PD-1 might control the virus in those with chronic infection.
Therapeutic HIV vaccines could one day be part of a combination strategy for achieving a functional cure for HIV.
A Brazilian man with HIV is no longer in remission after more than 15 months off treatment.
HTI vaccines could become the backbone of a combination approach for achieving a functional cure.
An Argentine woman appears to be free of HIV long after stopping treatment.
The São Paulo Patient is no longer HIV-free after more than 15 months off treatment, but was it a relapse or reinfection?
The woman has had an undetectable viral load and a normal CD4 count for more than 12 years after stopping antiretroviral therapy.
Loreen Willenberg may be the first woman cured of HIV without a bone marrow transplant.
That’s the hope of research funded by a new Campbell Foundation grant.
The first person cured of HIV is now in home hospice care, after a recurrence of leukemia, with his loving partner at his side.
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.